Javascript must be enabled to continue!
Severe Hypoglycemia in Children With IDDM: A prospective population study, 1992–1994
View through CrossRef
OBJECTIVE
Is an increased incidence of severe hypoglycemia an unavoidable effect of improved metabolic control? And, if so, to what extent?
RESEARCH DESIGN AND METHODS
In 1992–1994, severe hypoglycemia was prospectively registered in our intensively treated IDDM population, 146 children 1–18 years of age with > 90% of the patients on ≥ 4 insulin injections per day. The two categories, “severe hypoglycemia with unconsciousness” (U hypoglycemia) and “severe hypoglycemia without unconsciousness but needing the assistance of another person” (NU hypoglycemia), were analyzed in relation to yearly mean HbA1c levels, insulin doses and proportion of short-acting insulin, age at onset, duration of diabetes, age, sex, and weight-to-height ratio.
RESULTS
Yearly mean HbA1c levels improved from 8.1 ± 1.6% in 1992 to 6.9 ± 1.3% in 1994. The yearly incidence of U hypoglycemia was 0.15–0.19 events per patient-year, seen in 10–16% of patients, showing no significant increase from 1992–1994. For NU hypoglycemia, slightly increasing figures from 1.01 to 1.26 events per patient-year, seen in 27–38% of patients yearly, were reported. There was no significant correlation between severe (U or NU) hypoglycemia and HbA1c, but still an association was seen in certain calculations. In multiple regression analysis, U hypoglycemia was not related to any factor, but the square root of the rate of NU hypoglycemia was related to lower HbA1c levels (P = 0.0003), higher insulin doses (IU · kg−1 · 24 h−1) (P = 0.0024), and a lower proportion of short-acting insulin out of the total daily insulin dose (P = 0.031).
CONCLUSIONS
Multiple-dose insulin therapy with rather low yearly mean HbA1c values causes a slight increase of NU hypoglycemia but no increase of U hypoglycemia in our population of children with IDDM. Near physiological HbA1c levels may be achieved without any pronounced risk of increasing the incidence of severe hypoglycemia when multiple-injection insulin therapy is combined with adequate self-control based on psychosocial support and active education.
Title: Severe Hypoglycemia in Children With IDDM: A prospective population study, 1992–1994
Description:
OBJECTIVE
Is an increased incidence of severe hypoglycemia an unavoidable effect of improved metabolic control? And, if so, to what extent?
RESEARCH DESIGN AND METHODS
In 1992–1994, severe hypoglycemia was prospectively registered in our intensively treated IDDM population, 146 children 1–18 years of age with > 90% of the patients on ≥ 4 insulin injections per day.
The two categories, “severe hypoglycemia with unconsciousness” (U hypoglycemia) and “severe hypoglycemia without unconsciousness but needing the assistance of another person” (NU hypoglycemia), were analyzed in relation to yearly mean HbA1c levels, insulin doses and proportion of short-acting insulin, age at onset, duration of diabetes, age, sex, and weight-to-height ratio.
RESULTS
Yearly mean HbA1c levels improved from 8.
1 ± 1.
6% in 1992 to 6.
9 ± 1.
3% in 1994.
The yearly incidence of U hypoglycemia was 0.
15–0.
19 events per patient-year, seen in 10–16% of patients, showing no significant increase from 1992–1994.
For NU hypoglycemia, slightly increasing figures from 1.
01 to 1.
26 events per patient-year, seen in 27–38% of patients yearly, were reported.
There was no significant correlation between severe (U or NU) hypoglycemia and HbA1c, but still an association was seen in certain calculations.
In multiple regression analysis, U hypoglycemia was not related to any factor, but the square root of the rate of NU hypoglycemia was related to lower HbA1c levels (P = 0.
0003), higher insulin doses (IU · kg−1 · 24 h−1) (P = 0.
0024), and a lower proportion of short-acting insulin out of the total daily insulin dose (P = 0.
031).
CONCLUSIONS
Multiple-dose insulin therapy with rather low yearly mean HbA1c values causes a slight increase of NU hypoglycemia but no increase of U hypoglycemia in our population of children with IDDM.
Near physiological HbA1c levels may be achieved without any pronounced risk of increasing the incidence of severe hypoglycemia when multiple-injection insulin therapy is combined with adequate self-control based on psychosocial support and active education.
Related Results
Hypoglycemia
Hypoglycemia
AbstractIatrogenic hypoglycemia often causes recurrent morbidity and precludes maintenance of lifelong euglycemia in people with diabetes mellitus. It causes an array of neurogenic...
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
<i>Objectives: </i>The Hypoglycemia Fear Survey II (HFS-II) is a
well-validated measure of fear of hypoglycemia in people with type 1
diabetes. The aim of this study w...
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
<i>Objectives: </i>The Hypoglycemia Fear Survey II (HFS-II) is a
well-validated measure of fear of hypoglycemia in people with type 1
diabetes. The aim of this study w...
The Psychosocial Impact of Severe Hypoglycemic Episodes on Spouses of Patients With IDDM
The Psychosocial Impact of Severe Hypoglycemic Episodes on Spouses of Patients With IDDM
OBJECTIVE
No previous studies have examined the psychosocial impact of severe hypoglycemic episodes in IDDM patients on their spouses. This study compared spouses...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
IntroductionRecurrent episodes of insulin-induced hypoglycemia in patients with diabetes mellitus can result in hypoglycemia-associated autonomic failure (HAAF), which is character...
Hypoglycemia Prevention Practice and Associated Factors Among Diabetic Mellitus Patients on Follow-up at Public Hospitals of Central Zone, Tigray, Ethiopia, 2018.
Hypoglycemia Prevention Practice and Associated Factors Among Diabetic Mellitus Patients on Follow-up at Public Hospitals of Central Zone, Tigray, Ethiopia, 2018.
Abstract
Background
Hypoglycemia is an acute medical situation that occurs when blood sugar falls below the recommended level. Even though, hypoglycemia prevention practic...
Hypoglycemia prevention practice and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analyssis
Hypoglycemia prevention practice and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analyssis
Background
Hypoglycemia is an urgent, life-threatening condition that requires prompt recognition and treatment for diabetes mellitus patients to prevent organ and brain damage. Hy...

